Galenicum Axium, a subsidiary that focuses on the development of licenses and distribution of medicines for other companies and is one of the company's main sources...
Oniria Therapeutics is a company dedicated to the development of precision drugs in the preclinical stage focused on the elimination of persistent tumor cells, which are...
In 2022, the company's results stood at €15.6 million, which translates into a rise of 47.2% compared to the previous year. However, in the same period,...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...
Vitro works mainly with public health, which represents between 80% and 85% of its business, and with large private chains. The biotech company has grown to...
The diagnostics sector has the highest expected growth rate until 2030. The report highlights the need for smart financing in order to achieve efficient investment in...
The Czech company Meddihub, which provides telehealth care services, will reach the Spanish market at the end of the year. The company currently has a presence...
According to the latest public financial data of the Catalan company, in 2018, Bioiberica earned €34.2 million in 2018, more than double compared to 2017, when...
With this round, the company also plans to consolidate itself in the Spanish market with its portfolio of products, to later go international through the European...
Last March, the biopharmaceutical company Libera Bio signed a new collaboration agreement, after partnering with Immunoprecise Antibodies, a subsidiary of Talem Therapeutics, to discover multi-target antibodies...